Brizy

Brizy

Syrup

🧬 Levosalbutamol 🏢 Eskayef Pharmaceuticals Ltd.
Generic Name Levosalbutamol
Manufacturer Eskayef Pharmaceuticals Ltd.
Unit Price 60 ml bottle: ৳ 32.00

🔹 Indications

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Pharmacology

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Dosage & Administration

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Interaction

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Contraindications

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Side Effects

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Pregnancy & Lactation

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Precautions & Warnings

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

🔹 Storage Conditions

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

💡 Frequently Asked Questions

Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
Brizy is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.

User Reviews

No reviews yet!
Be the first to share your experience.

Write a Review